Thermo Fisher Scientific (China) and Luca Healthcare announce a strategic collaboration to explore developing a digital patient assistant and digital medication adherence solutions to support direct-to-patient clinical trial services in China
-
Thermo Fisher Scientific (China) and Luca Healthcare announce a strategic collaboration to explore developing a digital patient assistant and digital medication adherence solutions to support direct-to-patient clinical trial services in China
06 Nov, 2021 Shanghai, November 6, 2021 – Th…
-
Shanghai Pharmaceuticals and Luca Healthcare announce a strategic collaboration to provide home drug delivery to rare disease patients on Luca Healthcare’s patient management platform
12 Oct, 2021 SPH Health Commerce, the Direct-to-Patient…
-
AstraZeneca (China) and Luca Healthcare announce a strategic partnership to develop out-of-hospital digital tools for screening and management of respiratory diseases and to explore digital solutions to support R&D and clinical trials in China
05 Nov, 2021 Shanghai, November 5, 2021 – As…
-
Sperogenix Therapeutics and Luca Healthcare announce a strategic collaboration to develop digital therapeutics for Sperogenix’s platform of rare disease treatments
10 Feb, 2022 Shanghai, February 10, 2022 – Sperog…
-
Cambridge Cognition and Luca Healthcare announce a strategic partnership and an exclusive licensing agreement to commercialize Cambridge Cognition’s suite of cognitive assessment tools and brain health products for the China market
29 Nov, 2022 Shanghai, Nov 28, 2022 – Cambridge C…
-
PwC (China) and Luca Healthcare announce a strategic partnership to accelerate collaboration to build digital health solutions for life sciences companies
17 Feb, 2023 Shanghai, February 17, 2023 – Strate…
-
Luca Healthcare joins global alliance initiated by DiMe to build digital measures for Alzheimer’s disease and related dementias
17 August, 2023 By working together with a balanced and…